B
Now Enrolling · 2025
Broaden Study · Eligibility Screener

Find out if you qualify for our
neuromodulation trials.

This confidential screener takes approximately 3–4 minutes and helps our clinical team assess your compatibility with current and upcoming research studies exploring device-based therapies for treatment-resistant depression.

All responses are confidential and used solely for research matching
No commitment required to complete the screener
A coordinator reviews every submission personally
01
Eligibility · Question 1 of 10

Have you been formally diagnosed with Major Depressive Disorder (MDD)?

This should be a diagnosis made by a licensed psychiatrist, psychologist, or physician. A self-reported or suspected diagnosis does not qualify at this stage.

Yes, formally diagnosed
I have a documented MDD diagnosis from a licensed clinician
No, not formally diagnosed
I have not received an official MDD diagnosis
02
Eligibility · Question 2 of 10

How long have you been living with MDD?

Duration of illness is an important factor in determining eligibility for certain neuromodulation protocols. Please select the option that best reflects your experience.

Less than 1 year
Diagnosed recently or symptoms began within the past year
1 – 2 years
3 – 5 years
More than 5 years
Chronic or recurrent depression lasting over five years
03
Eligibility · Question 3 of 10

How would you describe your current depressive symptoms?

Please reflect on the past two weeks when selecting your response.

Mild
Symptoms present but mostly manageable. Functioning relatively normally day-to-day.
Moderate
Noticeable impact on work, relationships, or daily activities most days.
Severe
Significant difficulty functioning. Symptoms are persistent and debilitating.
Very Severe / Treatment-Resistant
Chronic, debilitating symptoms that have not responded to multiple treatment attempts.
04
Eligibility · Question 4 of 10

In which areas has depression had the greatest impact? (Select all that apply)

This helps us understand the full scope of your experience.

Work or academic performance
Relationships and social functioning
Sleep and energy levels
Basic daily activities (hygiene, eating, leaving home)
Physical health and motivation
All of the above
05
Eligibility · Question 5 of 10

How many antidepressant medications have you tried that did not provide adequate relief?

Include all medications prescribed by a doctor for depression where you did not achieve significant symptom improvement, regardless of whether you completed the full course.

None
I have not tried antidepressant medications
1 medication
2 – 3 medications
4 – 5 medications
6 or more medications
Extensive medication history with minimal sustained benefit
06
Eligibility · Question 6 of 10

Which classes of medication have you been prescribed? (Select all that apply)

Select every category you've been prescribed, even if you've only tried one medication from that class.

SSRIs
e.g. Prozac, Zoloft, Lexapro, Celexa
SNRIs
e.g. Effexor, Cymbalta, Pristiq
Tricyclics (TCAs)
e.g. Amitriptyline, Nortriptyline
MAOIs
e.g. Phenelzine, Tranylcypromine
Atypical Antidepressants
e.g. Wellbutrin, Remeron, Trazodone
Augmentation Agents
e.g. Lithium, Abilify, Rexulti added to antidepressants
None / Unsure
07
Eligibility · Question 7 of 10

What is your current treatment status?

Understanding your current situation helps us determine which studies you may be eligible for right now.

Currently seeing a psychiatrist or prescriber
Actively receiving psychiatric care and medication management
In psychotherapy only (no medications)
Working with a therapist but not currently on psychiatric medication
Not currently in treatment
Managing independently without professional support at this time
Both medication and psychotherapy
Receiving combination treatment from multiple providers
08
Eligibility · Question 8 of 10

Have you previously undergone any neuromodulation or procedural treatments? (Select all that apply)

This includes any device-based, procedural, or interventional treatments you may have received for depression.

Electroconvulsive Therapy (ECT)
Transcranial Magnetic Stimulation (TMS / rTMS)
Ketamine or Esketamine (Spravato)
Vagus Nerve Stimulation (VNS)
tDCS or other brain stimulation
Deep Brain Stimulation (DBS)
Prior DBS implant for any indication
None of the above
09
Eligibility · Question 9 of 10

What is your age range?

Most of our active trials require participants to be between 22 and 70 years of age. Age criteria vary by specific study protocol.

Under 22
22 – 35
36 – 50
51 – 65
66 – 70
Over 70
10
Eligibility · Question 10 of 10

Are you able to commit to scheduled study visits over an extended period?

Neuromodulation trials typically require regular in-person visits to a study site over 6–24 months. Some visits may be weekly, particularly in the early phases.

Study site locations vary. A coordinator will discuss the nearest participating institution with you once your application is reviewed.
Yes, I can commit without significant difficulty
Flexible schedule and able to travel to study visits regularly
Yes, but it would be challenging
Willing to make it work despite schedule or logistical constraints
Unsure — depends on the study requirements
I'd need more information about visit frequency and location
No, I am not available for regular visits
Final Step · Contact Information

You're almost done.
Enter your details.

A clinical coordinator will personally review your screening responses and reach out within 48 hours to discuss next steps.

Please complete all fields before submitting.

By submitting this form, you consent to being contacted by the Broaden Study research team. Your information will not be shared with third parties. This screener does not constitute medical advice or a guarantee of trial eligibility.

Screening Complete

Thank you for completing the screener.

Based on your current responses, you may not meet the eligibility criteria for our active trials. Clinical trial criteria can be very specific and this is not a reflection of the severity of your experience.

Stay connected as new studies open.

New trials enroll regularly. By joining our newsletter, you'll be among the first to know when eligibility criteria change or new research studies become available.

If you believe you received this result in error, or if your situation changes, you can retake the screener at any time. Questions? study@broadenstudy.com

Application Received

Thank you.
We'll be in touch.

Your information has been securely submitted. A clinical coordinator will review your eligibility profile and reach out within 48 hours to discuss potential next steps and answer any questions.

What happens next?

You'll receive a confirmation email with a summary of your responses
A coordinator will review your profile against active study protocols
If matched, you'll be contacted to schedule an in-person consultation

Questions in the meantime? Reach us at study@broadenstudy.com

Email
support@broadenstudy.com
Phone
(888) 574-9174
Pages
HomeAboutEligibility ScreenerResearch ProcessParticipant PathwaysResearchNeural Circuit Explorer
Company
Terms of ServicePrivacy PolicyContact Us
© Broaden Study All Rights Reserved
Broaden Study is a clinical research and mental health innovation platform. The information provided on this website is for educational and research awareness purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Deep brain stimulation (DBS) is an investigational or specialized therapy that carries specific risks and safety considerations which should be discussed thoroughly with a clinical professional.